Table 4.
Anti-cholesterol drugs affecting resistin levels.
Serial no. | Drug name | Phase | NCT no/PMID |
---|---|---|---|
1. | Pitavastatin | Clinical study | 18,385,536 |
2. | PCSK9 monoclonal antibodies (AMG145, REGN727) | Phase 1 and Phase 2 | 24,217,159 |
Anti-cholesterol drugs affecting resistin levels.
Serial no. | Drug name | Phase | NCT no/PMID |
---|---|---|---|
1. | Pitavastatin | Clinical study | 18,385,536 |
2. | PCSK9 monoclonal antibodies (AMG145, REGN727) | Phase 1 and Phase 2 | 24,217,159 |